Rezolute (RZLT) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $3.58, -8.21% vs the prior close of $3.90.
- Volume 1.40M shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
RZLT slides 8.2% to $3.58, a 3-month low, 5 down days in a row. Closed at $3.58, -8.21% vs the prior close of $3.90. Day range $3.56–$3.99, opened at $3.90.
RZLT daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — RZLT slides 8.2% to $3.58, a 3-month low, 5 down days in a row
- Closed at $3.58, -8.21% vs the prior close of $3.90. Day range $3.56–$3.99, opened at $3.90.
- Volume was 1.40M shares, 0.9x its 50-day average of 1.56M.
- Price is -18.7% vs its 50-day average ($4.41) and -6.0% vs its 200-day average ($3.81).
- 52-week range $1.07–$11.46; today's close sits at 24% of that range, 68.8% below the 52-week high.
- That makes 5 straight losses.
Oct 15, 2026 — RZLT slides 7.8% to $3.90, 4 down days in a row
- Closed at $3.90, -7.80% vs the prior close of $4.23. Day range $3.90–$4.33, opened at $4.25.
- Volume was 2.12M shares, 1.4x its 50-day average of 1.54M.
- Price is -11.9% vs its 50-day average ($4.43) and +2.5% vs its 200-day average ($3.80).
- 52-week range $1.07–$11.46; today's close sits at 27% of that range, 66.0% below the 52-week high.
- That makes 4 straight losses.
Oct 14, 2026 — RZLT slides 8.2% to $4.23, 3 down days in a row
- Closed at $4.23, -8.24% vs the prior close of $4.61. Day range $4.21–$4.70, opened at $4.52.
- Volume was 1.69M shares, 1.1x its 50-day average of 1.56M.
- Price is -4.8% vs its 50-day average ($4.44) and +11.4% vs its 200-day average ($3.80).
- 52-week range $1.07–$11.46; today's close sits at 30% of that range, 63.1% below the 52-week high.
- That makes 3 straight losses.
- SEC filings that day: 8-K.
Oct 13, 2026 — RZLT slides 5.3% to $4.61
- Closed at $4.61, -5.34% vs the prior close of $4.87. Day range $4.56–$4.85, opened at $4.82.
- Volume was 1.51M shares, 1.0x its 50-day average of 1.56M.
- Price is +3.4% vs its 50-day average ($4.46) and +21.7% vs its 200-day average ($3.79).
- 52-week range $1.07–$11.46; today's close sits at 34% of that range, 59.8% below the 52-week high.
Oct 12, 2026 — RZLT ends flat (+0.0%) to $4.87
- Closed at $4.87, +0.00% vs the prior close of $4.87. Day range $4.72–$4.91, opened at $4.86.
- Volume was 1.01M shares, 0.7x its 50-day average of 1.55M.
- Price is +9.1% vs its 50-day average ($4.46) and +28.9% vs its 200-day average ($3.78).
- 52-week range $1.07–$11.46; today's close sits at 37% of that range, 57.5% below the 52-week high.
Oct 9, 2026 — RZLT jumps 5.0% to $4.87, a 1-month high, 3 up days in a row
- Closed at $4.87, +4.96% vs the prior close of $4.64. Day range $4.55–$4.91, opened at $4.60.
- Volume was 1.87M shares, 1.2x its 50-day average of 1.53M.
- Price is +9.2% vs its 50-day average ($4.46) and +29.3% vs its 200-day average ($3.77).
- 52-week range $1.07–$11.46; today's close sits at 37% of that range, 57.5% below the 52-week high.
- That makes 3 straight gains.
Oct 8, 2026 — RZLT jumps 5.9% to $4.64, a 1-month high
- Closed at $4.64, +5.94% vs the prior close of $4.38. Day range $4.32–$4.68, opened at $4.33.
- Volume was 2.20M shares, 1.5x its 50-day average of 1.50M.
- Price is +4.0% vs its 50-day average ($4.46) and +23.6% vs its 200-day average ($3.75).
- 52-week range $1.07–$11.46; today's close sits at 34% of that range, 59.5% below the 52-week high.
Oct 7, 2026 — RZLT rises 1.4% to $4.38
- Closed at $4.38, +1.39% vs the prior close of $4.32. Day range $4.23–$4.56, opened at $4.29.
- Volume was 1.69M shares, 1.1x its 50-day average of 1.49M.
- Price is -1.8% vs its 50-day average ($4.46) and +17.2% vs its 200-day average ($3.74).
- 52-week range $1.07–$11.46; today's close sits at 32% of that range, 61.8% below the 52-week high.
Oct 6, 2026 — RZLT ends flat (-0.2%) to $4.32
- Closed at $4.32, -0.23% vs the prior close of $4.33. Day range $4.15–$4.64, opened at $4.64.
- Volume was 2.19M shares, 1.5x its 50-day average of 1.47M.
- Price is -3.4% vs its 50-day average ($4.47) and +16.0% vs its 200-day average ($3.73).
- 52-week range $1.07–$11.46; today's close sits at 31% of that range, 62.3% below the 52-week high.
Oct 5, 2026 — RZLT jumps 8.0% to $4.33 on 3.0x normal volume
- Closed at $4.33, +7.98% vs the prior close of $4.01. Day range $3.82–$4.53, opened at $4.05.
- Volume was 4.20M shares, 3.0x its 50-day average of 1.41M — unusually heavy trading.
- Price is -3.5% vs its 50-day average ($4.49) and +16.6% vs its 200-day average ($3.71).
- 52-week range $1.07–$11.46; today's close sits at 31% of that range, 62.2% below the 52-week high.
- SEC filings that day: 8-K.
Oct 2, 2026 — RZLT dips 1.5% to $4.01
- Closed at $4.01, -1.47% vs the prior close of $4.07. Day range $3.96–$4.20, opened at $4.13.
- Volume was 1.65M shares, 1.2x its 50-day average of 1.42M.
- Price is -10.9% vs its 50-day average ($4.50) and +8.3% vs its 200-day average ($3.70).
- 52-week range $1.07–$11.46; today's close sits at 28% of that range, 65.0% below the 52-week high.
RZLT latest news & SEC filings
Every SEC filing by or about RZLT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Oct 7, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Oct 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 24, 2026 · Form 10-K — Annual report
Annual report (audited full-year financial statements and business review)
Fiscal year ended Jun 30, 2026:
- Net income: -$77.59M (prior year -$74.41M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.75 (prior year -$0.98) (loss narrowed vs Jun 30, 2025)
Sep 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Sep 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade RZLT
- Last results release: Sep 24, 2026 (8-K Item 2.02). Previous ones: May 12, 2026, Feb 12, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Dec 24, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.62% (largest 8.2%). That is a volatile stock.
- Liquidity: about 1.85M shares (≈$6.61M) trade per day on average.
- 52-week position: $3.58 vs a range of $1.07–$11.46 (24% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Daron Evans bought 10,000 shares on Mar 30, 2026.
- Latest filings: 8-K Oct 14, 2026; 8-K Oct 5, 2026; 10-K Sep 24, 2026.
- Share count: 96.72M shares outstanding (Sep 21, 2026), +6.5% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
RZLT market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 3.90 | 3.99 | 3.56 | 3.58 | 1.40M |
| Oct 15, 2026 | 4.25 | 4.33 | 3.90 | 3.90 | 2.12M |
| Oct 14, 2026 | 4.52 | 4.70 | 4.21 | 4.23 | 1.69M |
| Oct 13, 2026 | 4.82 | 4.85 | 4.56 | 4.61 | 1.51M |
| Oct 12, 2026 | 4.86 | 4.91 | 4.72 | 4.87 | 1.01M |
| Oct 9, 2026 | 4.60 | 4.91 | 4.55 | 4.87 | 1.87M |
| Oct 8, 2026 | 4.33 | 4.68 | 4.32 | 4.64 | 2.20M |
| Oct 7, 2026 | 4.29 | 4.56 | 4.23 | 4.38 | 1.69M |
| Oct 6, 2026 | 4.64 | 4.64 | 4.15 | 4.32 | 2.19M |
| Oct 5, 2026 | 4.05 | 4.53 | 3.82 | 4.33 | 4.20M |
| Oct 2, 2026 | 4.13 | 4.20 | 3.96 | 4.01 | 1.65M |
| Oct 1, 2026 | 4.14 | 4.18 | 4.04 | 4.07 | 981.20K |
| Sep 30, 2026 | 4.19 | 4.34 | 4.14 | 4.14 | 1.70M |
| Sep 29, 2026 | 4.55 | 4.57 | 4.07 | 4.09 | 1.52M |
| Sep 28, 2026 | 3.85 | 4.20 | 3.76 | 4.18 | 1.59M |
| Sep 25, 2026 | 3.99 | 4.05 | 3.87 | 3.90 | 2.05M |
| Sep 24, 2026 | 4.03 | 4.09 | 3.84 | 3.94 | 3.87M |
| Sep 23, 2026 | 4.05 | 4.13 | 3.98 | 4.00 | 1.68M |
| Sep 22, 2026 | 3.96 | 4.09 | 3.95 | 4.04 | 928.50K |
| Sep 21, 2026 | 3.84 | 3.93 | 3.73 | 3.91 | 1.08M |
About Rezolute
Rezolute (RZLT) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in REDWOOD CITY, CA. State of incorporation: NV. Fiscal year ends June 30. SEC CIK 1509261.
RZLT board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Nevan C Elam | CEO | Jul 7, 2026 |
| Philippe Fauchet | Director | Nov 21, 2025 |
| Erik Harris | Director | Nov 21, 2025 |
| Wladimir Hogenhuis | Director | Dec 17, 2025 |
| Nerissa Kreher | Director | Nov 21, 2025 |
| Young-Jin Kim | Director | Nov 21, 2025 |
| Gil M Labrucherie | Director | Nov 21, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Nevan C Elam | CEO | Jul 7, 2026 |
| Daron Evans | CFO | Jul 7, 2026 |
| Sunil Ratilal Karnawat | Chief Commercial Officer | Sep 3, 2026 |
| Brian Kenneth Roberts | Chief Medical Officer | Jul 7, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Mar 30, 2026 | Daron Evans | Buy | 10,000 | $2.85 |
| Mar 30, 2026 | Daron Evans | Buy | 10,000 | $2.85 |
| Mar 30, 2026 | Daron Evans | Buy | 10,000 | $2.85 |
| Mar 30, 2026 | Daron Evans | Buy | 10,000 | $2.85 |
| Dec 16, 2025 | Wladimir Hogenhuis | Buy | 5,650 | $1.69 |
| Dec 16, 2025 | Wladimir Hogenhuis | Buy | 5,650 | $1.69 |
| Dec 16, 2025 | Wladimir Hogenhuis | Buy | 5,650 | $1.69 |
| Dec 16, 2025 | Wladimir Hogenhuis | Buy | 5,650 | $1.69 |
| Dec 16, 2025 | Brian Kenneth Roberts | Buy | 28,000 | $1.70 |
| Dec 16, 2025 | Brian Kenneth Roberts | Buy | 28,000 | $1.70 |
| Dec 16, 2025 | Brian Kenneth Roberts | Buy | 28,000 | $1.70 |
| Dec 16, 2025 | Brian Kenneth Roberts | Buy | 28,000 | $1.70 |
| Dec 15, 2025 | Nevan C Elam | Buy | 32,000 | $1.59 |
| Dec 15, 2025 | Nevan C Elam | Buy | 32,000 | $1.59 |
| Dec 15, 2025 | Nevan C Elam | Buy | 32,000 | $1.59 |
RZLT financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Jun 30, 2026 | — | $-77.59M | -0.75 | $-64.64M |
| Jun 30, 2025 | — | $-74.41M | -0.98 | $-69.08M |
| Jun 30, 2024 | — | $-68.46M | -1.33 | $-57.37M |
| Jun 30, 2023 | — | $-51.79M | -1.01 | $-44.48M |
| Jun 30, 2022 | — | $-41.06M | -2.32 | $-39.62M |
Latest balance sheet: total assets $112.85M, total liabilities $12.16M, cash $10.62M (as of Jun 30, 2026).
RZLT earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Sep 24, 2026 | 8-K Item 2.02 (results) | $3.94 |
| May 12, 2026 | 8-K Item 2.02 (results) | $3.30 |
| Feb 12, 2026 | 8-K Item 2.02 (results) | $3.63 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $9.60 |
| Sep 17, 2025 | 8-K Item 2.02 (results) | $7.71 |
| May 13, 2025 | 8-K Item 2.02 (results) | $3.67 |
| Feb 12, 2025 | 8-K Item 2.02 (results) | $4.86 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $5.72 |
| Sep 19, 2024 | 8-K Item 2.02 (results) | — |
| May 15, 2024 | 8-K Item 2.02 (results) | — |
| Feb 13, 2024 | 8-K Item 2.02 (results) | — |
| Nov 13, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on RZLT
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.